Follicular fluid soluble receptor for advanced glycation end-products (sRAGE): A potential indicator of ovarian reserve

Journal of Clinical Endocrinology and Metabolism

Volumn 99, Issue 2, 2014, Pages

  Merhi, Zaher ^a   Irani, Mohamad ^b   Doswell, Angela D ^a   Ambroggio, Jennifer ^a  

^a Division of Reproductive Endocrinology and Infertility   (United States)

^b MAIMONIDES MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE FACTORS; ANTI-MULLERIAN HORMONE; BIOLOGICAL MARKERS; BODY MASS INDEX; FEMALE; FOLLICLE STIMULATING HORMONE; FOLLICULAR FLUID; GRANULOSA CELLS; HUMANS; OOCYTE RETRIEVAL; OOCYTES; OVARIAN FOLLICLE; OVULATION INDUCTION; RECEPTORS, IMMUNOLOGIC;

EID: 84893797589     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2013-3839     Document Type: Article

References (43)

1. Inagi R. Inhibitors of advanced glycation and endoplasmic reticulum stress. Methods Enzymol. 2011;491:361-380.
2. Piperi C, Adamopoulos C, Dalagiorgou G, Diamanti-Kandarakis E, Papavassiliou AG. Cross talk between advanced glycation and endoplasmic reticulum stress: emerging therapeutic targeting for metabolic diseases. J Clin Endocrinol Metab. 2012;97:2231-2242.
3. Yamagishi S, Nakamura K, Imaizumi T. Advanced glycation end products (AGEs) and diabetic vascular complications. Curr Diabetes Rev. 2005;1:93-106.
4. Diamanti-Kandarakis E, Piperi C, Korkolopoulou P, et al. Accumulation of dietary glycotoxins in the reproductive system of normal female rats. J Mol Med (Berlin, Germany). 2007;85:1413-1420.
5. Kalea AZ, Schmidt AM, Hudson BI. RAGE: a novel biological and genetic marker for vascular disease. Clin Sci (London, England: 1979). 2009;116:621-637.
6. Fujii EY, Nakayama M. The measurements of RAGE, VEGF, and AGEs in the plasma and follicular fluid of reproductive women: the influence of aging. Fertil Steril. 2010;94:694-700.
7. Seifer DB, Baker VL, Leader B. Age-specific serum anti-Mullerian hormone values for 17 120 women presenting to fertility centers within the United States. Fertil Steril. 2011;95:747-750.
8. Merhi Z, Messerlian GM, Minkoff H, et al. Comparison of serum and plasma measurements of Mullerian inhibiting substance. Fertil Steril. 2008;89:1836-1837.
9. Rice S, Christoforidis N, Gadd C, et al. Impaired insulin-dependent glucose metabolism in granulosa-lutein cells from anovulatory women with polycystic ovaries. Hum Reprod. 2005;20:373-381.
10. Mark AB, Poulsen MW, Andersen S, et al. Consumption of a diet low in advanced glycation endproducts for 4 weeks improves insulin sensitivity in overweight women [published ahead of print August 19, 2013]. Diabetes Care.
11. Merhi Z, Minkoff H, Feldman J, Macura J, Rodriguez C, Seifer DB. Relationship of bariatric surgery to Mullerian-inhibiting substance levels. Fertil Steril. 2008;90:221-224.
12. Seifer DB, Scott RT Jr, Bergh PA, et al. Women with declining ovarian reserve may demonstrate a decrease in day 3 serum inhibin B before a rise in day 3 follicle-stimulating hormone. Fertil Steril. 1999;72:63-65.
13. Seifer DB, MacLaughlin DT, Christian BP, Feng B, Shelden RM. Early follicular serum mullerian-inhibiting substance levels are associated with ovarian response during assisted reproductive technology cycles. Fertil Steril. 2002;77:468-471.
14. Broer SL, Eijkemans MJ, Scheffer GJ, et al. Anti-Mullerian hormone predicts menopause: a long-term follow-up study in normoovulatory women. J Clin Endocrinol Metab. 2011;96(8):2532-2539.
15. Merhi Z. Weight loss by bariatric surgery and subsequent fertility. Fertil Steril. 2007;87:430-432.
16. Merhi Z. Impact of bariatric surgery on female reproduction. Fertil Steril. 2009;92:1501-1508.
17. Merhi Z, Seifer DB,WeedonJ, et al. Circulating vitaminDcorrelates with serum antimullerian hormone levels in late-reproductive-aged women: Women's Interagency HIV Study. Fertil Steril. 2012;98: 228-234.
18. Tatone C, Amicarelli F. The aging ovary-the poor granulosa cells. Fertil Steril. 2013;99:12-17.
19. Tatone C, Amicarelli F, Carbone MC, et al. Cellular and molecular aspects of ovarian follicle ageing. Hum Reprod Update. 2008;14: 131-142.
20. de Bruin JP, Dorland M, Spek ER, et al. Age-related changes in the ultrastructure of the resting follicle pool in human ovaries. Biol Reprod. 2004;70:419-424.
21. Papachroni KK, Piperi C, Levidou G, et al. Lysyl oxidase interacts with AGE signalling to modulate collagen synthesis in polycystic ovarian tissue. J Cell Mol Med. 2010;14:2460-2469.
22. Franks S. Controversy in clinical endocrinology: diagnosis of polycystic ovarian syndrome: in defense of the Rotterdam criteria. J Clin Endocrinol Metab. 2006;91:786-789.
23. Catteau-Jonard S, Jamin SP, Leclerc A, Gonzales J, Dewailly D, di Clemente N. Anti-Mullerian hormone, its receptor, FSH receptor, and androgen receptor genes are overexpressed by granulosa cells from stimulated follicles in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2008;93:4456-4461.
24. Diamanti-Kandarakis E, Katsikis I, Piperi C, et al. Increased serum advanced glycation end-products is a distinct finding in lean women with polycystic ovary syndrome (PCOS). Clin Endocrinol (Oxf). 2008;69:634-641.
25. Diamanti-Kandarakis E, Piperi C, Patsouris E, et al. Immunohistochemical localization of advanced glycation end-products (AGEs) and their receptor (RAGE) in polycystic and normal ovaries. Histochem Cell Biol. 2007;127:581-589.
26. Kandaraki E, Chatzigeorgiou A, Piperi C, et al. Reduced ovarian glyoxalase-I activity by dietary glycotoxins and androgen excess: a causative link to polycystic ovarian syndrome. Mol Med (Cambridge, MA). 2012;18:1183-1189.
27. Jayaprakasan K, Campbell B, Hopkisson J, Johnson I, Raine-Fenning N. A prospective, comparative analysis of anti-Mullerian hormone, inhibin-B, and three-dimensional ultrasound determinants of ovarian reserve in the prediction of poor response to controlled ovarian stimulation. Fertil Steril. 2010;93:855-864.
28. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2[-δδC(T)] method. Methods. 2001;25:402-408.
29. Jinno M, Takeuchi M, Watanabe A, et al. Advanced glycation endproducts accumulation compromises embryonic development and achievement of pregnancy by assisted reproductive technology. Hum Reprod. 2011;26:604-610.
30. Malickova K, Jarosova R, Rezabek K, et al. Concentrations of sRAGE in serum and follicular fluid in assisted reproductive cycles- a preliminary study. Clin Lab. 2010;56:377-384.
31. Bonetti TC, BorgesEJr, Braga DP, IaconelliAJr, Kleine JP, Silva ID. Intrafollicular soluble receptor for advanced glycation end products (sRAGE) and embryo quality in assisted reproduction. Reprod Biomed Online. 2013;26:62-67.
32. Hirobe S, He WW, Lee MM, Donahoe PK. Mullerian inhibiting substance messenger ribonucleic acid expression in granulosa and Sertoli cells coincides with their mitotic activity. Endocrinology. 1992;131:854-862.
33. Hirobe S, He WW, Gustafson ML, MacLaughlin DT, Donahoe PK. Mullerian inhibiting substance gene expression in the cycling rat ovary correlates with recruited or graafian follicle selection. Biol Reprod. 1994;50:1238-1243.
34. Kim JH, Seibel MM, MacLaughlin DT, et al. The inhibitory effects of mullerian-inhibiting substance on epidermal growth factor induced proliferation and progesterone production of human granulosa- luteal cells. J Clin Endocrinol Metab. 1992;75:911-917.
35. May JV, Frost JP, Schomberg DW. Differential effects of epidermal growth factor, somatomedin-C/insulin-like growth factor I, and transforming growth factor-β on porcine granulosa cell deoxyribonucleic acid synthesis and cell proliferation. Endocrinology. 1988; 123:168-179.
36. Durlinger AL, Gruijters MJ, Kramer P, et al. Anti-Mullerian hor- mone inhibits initiation of primordial follicle growth in the mouse ovary. Endocrinology. 2002;143:1076-1084.
37. Merhi Z, Minkoff H, Lambert-Messerlian GM, Macura J, Feldman J, Seifer DB. Plasma brain-derived neurotrophic factor in women after bariatric surgery: a pilot study. Fertil Steril. 2009;91(suppl 4):1544-1548.
38. Merhi Z, Pal L. Effect of weight loss by bariatric surgery on the risk of miscarriage. Gynecol Obstet Invest. 2007;64:224-227.
39. Jia X, Chang T, Wilson TW, Wu L. Methylglyoxal mediates adipocyte proliferation by increasing phosphorylation of Akt1. PloS One. 2012;7:e36610.
40. Leuner B, Max M, Thamm K, et al. RAGE influences obesity in mice. Effects of the presence of RAGE on weight gain, AGE accumulation, and insulin levels in mice on a high fat diet. Zeitschr Gerontol Geriatr. 2012;45:102-108.
41. Koyama H, Shoji T, Yokoyama H, et al. Plasma level of endogenous secretory RAGE is associated with components of the metabolic syndrome and atherosclerosis. Arterioscler Thromb Vasc Biol. 2005;25:2587-2593.
42. Vazzana N, Guagnano MT, Cuccurullo C, et al. Endogenous secretoryRAGEin obese women: association with platelet activation and oxidative stress. J Clin Endocrinol Metab. 2012;97:E1726-E1730.
43. Gaens KH, Ferreira I, van der Kallen CJ, et al. Association of polymorphism in the receptor for advanced glycation end products (RAGE) gene with circulating RAGE levels. J Clin Endocrinol Metab. 2009;94:5174-5180.